CSTL
CASTLE BIOSCIENCES INC
Key Financials
Net Income
$-24158000
↓ 232.4%
Revenue
$344.2M
↑ 3.7%
Gross Profit
$53.0M
↑ 262.1%
Operating Income
$-42810000
↓ 593.8%
Total Liabilities
$107.7M
↑ 42.8%
Total Assets
$578.6M
↑ 8.9%
Shareholders' Equity
$470.9M
↑ 3.3%
EPS (Diluted)
$-0.83
↓ 233.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 10/1/2026 | View on SEC |
| 4 | 10/1/2026 | View on SEC |
| 4 | 9/23/2026 | View on SEC |
| 4 | 9/16/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 144 | 9/14/2026 | View on SEC |
| 144 | 9/11/2026 | View on SEC |
| 4 | 9/3/2026 | View on SEC |
| 4 | 9/2/2026 | View on SEC |
| 4 | 9/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CSTL |
| Company Name | CASTLE BIOSCIENCES INC |
| CIK | 1447362 |
| Sector | Services-Medical Laboratories |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 866-788-9007 |